Psyence Biomedical Ltd
PBM4.770USD
+4.335+999.08%
Close 05/05, 16:00（ET）Quotes delayed by 15 min
851.65KMarket Cap
LossP/E TTM
More Details of Psyence Biomedical Ltd Company
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Company Info
Company codePBM
Company namePsyence Biomedical Ltd
IPO dateDec 10, 2021
Founded at2023
CEODr. Neil Maresky
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 10
Address121 Richmond Street West Penthouse
CityTORONTO
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeM5H 2K1
Phone17744604171
Website
Company codePBM
IPO dateDec 10, 2021
Founded at2023
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sun, Feb 23
Update time: Sun, Feb 23
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Psyence Group Inc
14.60%
Hudson Bay Capital Management LP
8.17%
Harraden Circle Investments, LLC
3.92%
White Lion Capital LLC
2.15%
Essential Planning, LLC
1.58%
Other
69.58%
Shareholder Statistics
Shareholder
Proportion
Psyence Group Inc
14.60%
Hudson Bay Capital Management LP
8.17%
Harraden Circle Investments, LLC
3.92%
White Lion Capital LLC
2.15%
Essential Planning, LLC
1.58%
Other
69.58%
Type
Shareholder
Proportion
Corporation
15.60%
Hedge Fund
12.97%
Investment Advisor
3.32%
Venture Capital
2.30%
Research Firm
0.28%
Other
65.54%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
44
195.77K
4.21%
+174.05K
2024Q4
82
948.20K
24.27%
+587.08K
2024Q3
88
169.92K
15.90%
-186.51K
2024Q2
92
159.62K
36.84%
-203.47K
2024Q1
96
157.41K
35.61%
-211.56K
2023Q4
88
18.95K
16.18%
-253.66K
2023Q3
87
16.58K
55.18%
-252.44K
2023Q2
86
17.96K
50.97%
-264.02K
2023Q1
85
19.55K
55.14%
-329.89K
2022Q4
82
277.86K
79.72%
-42.11K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Psyence Group Inc
678.72K
14.99%
+612.05K
+918.08%
Mar 25, 2025
Hudson Bay Capital Management LP
380.00K
8.39%
+380.00K
--
Dec 31, 2024
Harraden Circle Investments, LLC
182.32K
4.03%
+137.59K
+307.61%
Dec 31, 2024
White Lion Capital LLC
100.00K
2.21%
+100.00K
--
Dec 04, 2024
Essential Planning, LLC
73.28K
1.62%
+73.28K
--
Dec 31, 2024
AdvisorShares Investments, LLC
26.92K
0.59%
+10.49K
+63.84%
Dec 31, 2024
HRT Financial LP
26.13K
0.58%
+25.78K
+7.50K%
Dec 31, 2024
Launchpad Ignition Holdings LLC
15.92K
0.35%
+15.92K
--
Mar 31, 2024
UBS Financial Services, Inc.
12.71K
0.28%
+12.51K
+6.26K%
Dec 31, 2024
Virtu Americas LLC
12.69K
0.28%
+12.69K
--
Dec 31, 2024
View more
Related ETFs
Update time: 4 minutes ago
Update time: 4 minutes ago
Name
Proportion
AdvisorShares Psychedelics ETF
0.26%
AdvisorShares Psychedelics ETF
Proportion0.26%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1
Date
Type
Ratio
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1
Nov 12, 2024
Merger
75<1